Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03246620Phase 4Terminated
Phase 4, randomised, double-blind trial of olanzapine (3 arms), sponsored by The University of Hong Kong. Primary endpoint: Time to achieve adequate sedation at 60 minutes. Started Sep 2017; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03246620.